Convatec (CTEC.L)
Convatec is a specialist medical technology company providing life-improving solutions for wound, ostomy, continence, and infusion care.
What Convatec does
Convatec is a global medical products and technologies company focused on advanced wound care, ostomy care, continence and critical care, and infusion care. The company provides innovative solutions designed to improve the lives of people with chronic and acute medical conditions.
Themes: advanced wound care, ostomy care, continence care, infusion care, chronic disease management
Fundamentals
- Price£2.25 as of 2026-08-03 close
- Market capn/a company fundamentals are not available for UK-listed companies in our data
- 1-year return-2.4% 2025-08-01 close £2.31 → 2026-08-03 close £2.25
- P/En/a company fundamentals are not available for UK-listed companies in our data
- Net marginn/a company fundamentals are not available for UK-listed companies in our data
- Gross marginn/a company fundamentals are not available for UK-listed companies in our data
- ROEn/a company fundamentals are not available for UK-listed companies in our data
- Debt / equityn/a company fundamentals are not available for UK-listed companies in our data
- Revenue growth (YoY)n/a company fundamentals are not available for UK-listed companies in our data
- Revenue CAGR (3y)n/a company fundamentals are not available for UK-listed companies in our data
- Betan/a we do not track a market benchmark for UK-listed companies
Dividend: company fundamentals are not available for UK-listed companies in our data.
How Convatec looks technically
Convatec (CTEC.L) is trading 0.5% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 213 trading days ago — a "death cross", a bearish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 43, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 5 trading days ago (its momentum flipped positive). It made a new 20-day high about 4 trading days ago. Trading volume is unusually light — only about 0% of its 30-day average.
Trend
| Distance from the 200-day | -0.5% | it is trading 0.5% below its 200-day average, the long-term trend line — a long-term downtrend |
|---|---|---|
| 50-day moving average | £2.11 | its average price over the last 50 trading days — a short-term trend line — is £2.11 |
| 200-day moving average | £2.26 | its average price over the last 200 trading days — the long-term trend line — is £2.26 |
| Since the 50/200 cross | 213 sessions | its 50-day average crossed below its 200-day average about 213 trading days ago — a "death cross", a bearish long-term signal |
| Trend strength (14-day ADX) | 42.5 | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 43, with buyers in control |
Momentum
| 14-day RSI | 59.9 | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30) |
|---|---|---|
| Since the MACD crossed zero | 5 sessions | MACD, a trend-momentum gauge, turned bullish about 5 trading days ago (its momentum flipped positive) |
Range
| 52-week high | £2.59 | its highest closing price over the past year (about 252 trading days) was £2.59 |
|---|---|---|
| From the 52-week high | -13.1% | it is 13.1% below its 52-week high (its highest price of the past year) |
| Above the 52-week low | +16.8% | it is 16.8% above its 52-week low (its lowest price of the past year) |
| Below the 52-week high | 13.1% | it is 13.1% below its highest point of the past year |
| Since a 20-day breakout | 4 sessions | it made a new 20-day high about 4 trading days ago |
| Since a 55-day breakout | 4 sessions | it made a new 55-day high about 4 trading days ago |
| All-time high | £3.49 | its highest closing price on record is £3.49 (set on 2017-06-05) |
| From the all-time high | -35.4% | it is 35.4% below its all-time high |
| All-time low | £1.13 | its lowest closing price on record is £1.13 (set on 2019-02-14) |
| Above the all-time low | +99.0% | it is 99.0% above its all-time low |
Volatility
| Band width vs its own 6 months | 42nd percentile | day-to-day price swings are about average versus its own recent 6-month history |
|---|---|---|
| Bollinger bands (20-day, ±2σ) | £2.06 – £2.18 – £2.30 | most of its recent trading has stayed between about £2.06 and £2.30 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles |
Volume
| Volume vs its 30-day average | 0.00× | trading volume is unusually light — only about 0% of its 30-day average |
|---|
Screens: Trading below the 200-day moving average · MACD just crossed bullish (12/26/9) · in a strong, established uptrend (ADX) | Learn: moving average · golden cross · adx · rsi · macd · breakout · volume and relative volume
Based on daily closing prices as of 2026-08-03. Describes past price behavior only — informational, not financial advice.
Key risks (from latest filing)
["intense competition in medical device markets","reliance on global supply chains and manufacturing capabilities","regulatory scrutiny and product quality requirements"]
Competitors & peers
- Coloplast (COLO-B.CO)
- Hollister Incorporated
- Smith & Nephew (SN.L)
- Molnlycke Health Care
- B. Braun Melsungen AG
- Medtronic (MDT)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare CTEC.L vs…
Frequently asked questions
What does Convatec (CTEC.L) do?
Convatec is a global medical products and technologies company focused on advanced wound care, ostomy care, continence and critical care, and infusion care. The company provides innovative solutions designed to improve the lives of people with chronic and acute medical conditions.
Who are Convatec's (CTEC.L) competitors?
Notable peers of Convatec (CTEC.L) include Coloplast (COLO-B.CO), Hollister Incorporated, Smith & Nephew, Molnlycke Health Care and B. Braun Melsungen AG. This peer set is informational only — not financial advice.
Is Convatec (CTEC.L) overbought or oversold right now?
Convatec (CTEC.L) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 60, in the neutral middle (as of 2026-08-03). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on CTEC.L come from?
Fundamentals and prices come from market data. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data. Prices are delayed daily-close data.
Last updated 2026-08-03.
Informational only — NOT financial advice. All figures are delayed daily-close data from market data, shown with their as-of date.